Ad hoc announcement pursuant to Art. 53 LR FDA also approved complementary diagnostic imaging agent, Locametz®, after radiolabeling with gallium-68 for the identification of PSMA-positive lesions2 Metastatic prostate cancer has… Read More
Entrepreneurs strengthening market position post-pandemic EY Canada is honoured to announce the regional finalists in the EY Entrepreneur Of the Year® 2022 Pacific program today. Selected by an independent panel of judges,… Read More
All patients with IgAN in Cohort 1 have transitioned to subcutaneous (SC) dosing, and BION-1301 remains well-tolerated, with no serious adverse events (SAEs) and no treatment discontinuations due to adverse… Read More
The Newly Founded Company, Epitopea, Has Secured $14 Million in Seed Financing to Advance the Ground-breaking Tumor-Specific Antigen (TSA) Research of Drs. Claude Perreault and Pierre Thibault at the Université… Read More
TORONTO – adMare BioInnovations is pleased to announce the appointment of Dr. Christine Allen as Vice-President, Ecosystem Development. Dr. Allen will continue adMare’s leadership of Canada’s strong life sciences ecosystem through… Read More
